Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertram Pitt

Showing results (81-90 of 687) with videos related to

Pageof 69
Sort By:
Clinical Kidney Journal|August 2, 2023
Sodium polystyrene is unsafe and should not be prescribed for the treatment of hyperkalaemia: <i>primum non nocere</i>!Patrick Rossignol, Bertram Pitt
Pharmacological Research|July 30, 2016
Potassium lowering agents: Recommendations for physician and patient education, treatment reappraisal, and serial monitoring of potassium in patients with chronic hyperkalemiaBertram Pitt, Patrick Rossignol
Circulation|June 3, 2024
The Future of Clinical TrialsFaiez Zannad, Bertram Pitt
European Journal of Heart Failure|February 4, 2022
A promise unfulfilled: the use of mineralocorticoid receptor antagonists in patients with heart failure and a reduced left ventricular ejection fractionBertram Pitt, Murray Epstein
Journal of the American College of Cardiology|July 23, 2021
Heart Failure and Chronic Kidney Disease Patients: First It Is Necessary to ActPatrick Rossignol, Bertram Pitt
European Heart Journal|October 12, 2017
Serum potassium in patients with chronic heart failure: once we make a U-turn where should we go?Bertram Pitt, Patrick Rossignol
American Journal of Hypertension|January 10, 2024
Moving Forward by Looking Backwards: The Role of Combination Therapy With a Mineralocorticoid Receptor Antagonist and a Thiazide Diuretic in Patients With HypertensionBertram Pitt, Anand Vaidya
Cleveland Clinic Journal of Medicine|March 22, 2006
Aldosterone receptor antagonists for heart failure: current status, future indicationsBertram Pitt, Sanjay Rajagopalan
Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
Withdrawal of cerivastatin from the world marketCurt D Furberg, Bertram Pitt
Hypertension (Dallas, Tex. : 1979)|May 29, 2025
Are Diuretics a Clandestine Risk Factor for Patients With Treatment-Resistant Hypertension?Bertram Pitt, Christopher S Wilcox
Pageof 69

Showing results (81-90 of 687) with videos related to

Sort By:
Pageof 69
Clinical Kidney Journal|August 2, 2023
Sodium polystyrene is unsafe and should not be prescribed for the treatment of hyperkalaemia: <i>primum non nocere</i>!Patrick Rossignol, Bertram Pitt
Pharmacological Research|July 30, 2016
Potassium lowering agents: Recommendations for physician and patient education, treatment reappraisal, and serial monitoring of potassium in patients with chronic hyperkalemiaBertram Pitt, Patrick Rossignol
Circulation|June 3, 2024
The Future of Clinical TrialsFaiez Zannad, Bertram Pitt
European Journal of Heart Failure|February 4, 2022
A promise unfulfilled: the use of mineralocorticoid receptor antagonists in patients with heart failure and a reduced left ventricular ejection fractionBertram Pitt, Murray Epstein
Journal of the American College of Cardiology|July 23, 2021
Heart Failure and Chronic Kidney Disease Patients: First It Is Necessary to ActPatrick Rossignol, Bertram Pitt
European Heart Journal|October 12, 2017
Serum potassium in patients with chronic heart failure: once we make a U-turn where should we go?Bertram Pitt, Patrick Rossignol
American Journal of Hypertension|January 10, 2024
Moving Forward by Looking Backwards: The Role of Combination Therapy With a Mineralocorticoid Receptor Antagonist and a Thiazide Diuretic in Patients With HypertensionBertram Pitt, Anand Vaidya
Cleveland Clinic Journal of Medicine|March 22, 2006
Aldosterone receptor antagonists for heart failure: current status, future indicationsBertram Pitt, Sanjay Rajagopalan
Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
Withdrawal of cerivastatin from the world marketCurt D Furberg, Bertram Pitt
Hypertension (Dallas, Tex. : 1979)|May 29, 2025
Are Diuretics a Clandestine Risk Factor for Patients With Treatment-Resistant Hypertension?Bertram Pitt, Christopher S Wilcox
Pageof 69